AI Resilience Report forBioengineers and Biomedical Engineers

- Lab and process tasks: Researchers are building “intelligent” lab systems where robots run experiments and AI analyzes the data. For example, one team showed a platform that fully automated a bioprocess experiment – doing the testing and even redesigning the next steps with minimal human help ^[1]. In biotech manufacturing (like fermentation or protein production), AI models are now used to optimize conditions and predict yields, helping engineers improve processes ^{[2] [1]}.

However, humans still set goals and handle unexpected problems. - Information tasks: Tools already exist to help with reading literature and writing reports. Automated programs can scan scientific papers, pick out key findings, and even outline summaries ^{[3] [1]}. ChatGPT and similar AI can draft text or slide content quickly ^[1].

This saves time on routine writing, but experts must check and add ideas – one review notes that AI “is far from being a substitute for the knowledge, creativity, and critical thinking of human experts” ^{[1] [3]}. - Design tasks: Many design jobs (like creating medical devices or custom software) still rely on human creativity. AI does help in some ways: for instance, modern prosthetic limbs use machine learning to interpret nerve signals so they move more naturally ^{[1] [1]}. But engineers are the ones who build and test these devices and use AI tools as assistants, not replacements.

- Available tools: Basic AI tools (e.g., data analysis software, literature search wizards, writing assistants) are widely available ^{[1] [3]}. Biomedical engineers can use these to speed up routine work. However, AI systems tailored to specific bioengineering tasks are rare.

Developing custom AI usually requires special research and lots of data. - Costs versus labor: Biomedical engineers earn around $107,000 a year on median ^[4]. In theory, AI could reduce labor costs if it handles work well. But building, testing and validating an AI system can be very expensive.

Many AI projects never get enough funding to move from lab to real-world use ^[5]. Companies must weigh the high upfront cost of AI against saving on salaries over time. - Regulation and trust: Healthcare work is heavily regulated. Any AI solution must pass strict safety and privacy rules before it’s used.

Experts note that this slows adoption – for example, many AI tools “lack adequate alignment to regulatory pathways” which hinders their use in practice ^[5]. Hospital staff also worry about trusting “black box” algorithms. Doctors and patients usually expect a human expert to check AI recommendations so mistakes won’t happen ^{[6] [5]}.